Low acceptance of HSV-2 testing among high-risk women

International Journal of STD and AIDS

Volumn 22, Issue 6, 2011, Pages 329-331

  Roth, A M ^a,b,c   Dodge, B M ^b,c   van der Pol, B ^a,b,c   Reece, M ^b,c   Zimet, G D ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c Physical Education and Recreation   (United States)

Author keywords

Community court; Community based screening; Genital herpes; Herpes simplex virus 2; Medical decision making; Women's sexual health

Indexed keywords

ADULT; ARTICLE; FEMALE; HEALTH CARE COST; HERPES SIMPLEX VIRUS 2; HIGH RISK POPULATION; HUMAN; IMMUNOASSAY; INFECTION RISK; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; SCREENING TEST; UNITED STATES;

ADOLESCENT; ADULT; CRIMINALS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HUMANS; MASS SCREENING; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; RISK-TAKING;

EID: 79959531829     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2010.010399     Document Type: Article

References (11)

1. Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006;296:964-73
2. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis 2002;185:45-52
3. Freeman EE, Weiss HA, Glynn JR, et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006;20:73-83
4. Mertz GJ. Asymptomatic shedding of herpes simplex virus 1 and 2: implications for prevention of transmission. J Infect Dis 2008;198:1098-100
5. Wald A, Zeh J, Selke S, et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 2000;342:844-50
6. Fife KH, Van Der Pol B, Roth AM, et al. Implementation of routine access to herpes simplex virus type 2 antibody testing in a public health sexually transmitted disease clinic. STD 2009;36:724-8
7. Fife KH, Bernstein DI, Tu W, et al. Predictors of herpes simplex virus type 2 antibody positivity among persons with no history of genital herpes. STD 2004;31:676-81
8. Rosenstock IM. The health belief model and preventive health behavior. Health Educ Monogr 1974;2:354-86
9. Zimet G, Rosenthal S, Fortenberry JD, et al. Factors predicting the acceptance of herpes simplex virus type 2 antibody testing among adolescents and young adults. Sex Trans Dis 2004;31:665-9
10. Philip SS, Ahrens K, Shayevich C, et al. Evaluation of a new point-of-care serologic assay for herpes simplex virus type 2 infection. Clin Infect Dis 2008;47:e79-e82
11. Mays RM, Zimet GD, Winston Y, et al. Human papillomavirus, genital warts, Pap smears, and cervical cancer: Knowledge and beliefs of adolescent and adult women. Health Care Women Int 2000;21:361-74